265 17BETA-ESTRADIOL-INDUCED UP-REGULATION OF TYPE II COLLAGEN EXPRESSION IS MEDIATED BY ER ALPHA/SP/SOX-9/P300 COMPLEX THROUGH COL2A1 PROMOTER/FIRST INTRON INTERACTIONS IN DIFFERENTIATED AND DEDIFFERENTIATED ARTICULAR CHONDROCYTES

Abstract

Purpose: Type II collagen, encoded by COL2A1 gene, is a phenotypic marker of articular cartilage whose expression is strongly decreased during osteoarthritis (OA) process. Specific proteins (Sp) and Sox proteins have been previously characterized to be major regulators of this gene. Besides, the existence of a link between estrogen deprivation and osteoarthritis in postmenopausal women suggests that 17β-estradiol (17β-E2) may be a critical modulator of cartilaginous matrix homeostasis. The aim of present study was to investigate the molecular mechanisms regulating type II collagen gene expression under the effect of 17β-E2, and to characterize the genomic pathway via estrogen receptors (ER). Methods: Articular chondrocytes were isolated from 3-week old rabbits and incubated for 24 hours with increasing concentrations of 17β-E2 (0 to 10 nM). Nuclear proteins were extracted and submitted to gel retardation assays in order to determine Sp and Sox proteins binding activities on COL2A1 gene. In some experiments, relative expression of Sp1/Sp3 or Sox-9 was inhibited by siRNAs strategies. Moreover, chromatin immunoprecipitation was used to study protein-protein interactions on COL2A1 promoter and enhancer sequences. Results: We have previously shown that 17β-E2 could stimulate type II collagen neosynthesis, protein level and corresponding steady-state levels of COL2A1 mRNAs in primary and in vitro dedifferentiated rabbit articular chondrocytes. 17β-E2 action was mediated, in part, by an ERα/Sp transactivating effect on the -266/-63 bp region of COL2A1 proximal promoter. Our new data showed that 17β-E2 also increases the DNA-binding activities of Sp1/Sp3 and Soxs proteins to the first intron region including COL2A1 specific enhancer. In addition, Sp1, Sp3 and Sox-9 siRNAs prevented hERα66-induced transactivation of COL2A1, suggesting that these factors are required for COL2A1 up-regulation. Moreover, chromatin immunoprecipitation assays indicated that ERα physically interacts in vivo with Sp1, Sp3, Sox-9 and p300 transcription factors, on both COL2A1 promoter and enhancer sequences. Thus, considering that all these transcription factors are known to act in concert, we proposed that 17β-E2 in vivo effect could be mediated by a bridging complex, composed of ERα, Sp1, Sp3, Sox-9 and p300 transcription factors, which could establish a physical link between the two main cisregulatory regions of the gene, and consequently, may facilitate COL2A1 transcription process. Besides, this transcriptional activation of COL2A1 gene requires the ERα transactivation domains, AF-1 and AF-2, as demonstrated by using ERα mutants lacking these functional domains. Conclusions: Understanding the molecular basis for 17β-E2/ERα induction of COL2A1 transcription provides new insights into molecular mechanisms of OA and could be therefore attractive for some applications in the tissue engineering of cartilage.